$1.03
0.033.00%
After Hours: 8:09 AM EDT
15 minutes delayed
Comments
Loading...
Sonnet BioTherapeutics (SONN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSonnet BioTherapeutics (NASDAQ:SONN) Stock Quotes, Forecast and News Summary
Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
| Open | $1.01 |
| Close | - |
| Volume / Avg. | 27.47K / 139.93K |
| Day Range | $0.94 - $1.01 |
| 52 Wk Range | 0.62 - 3.46 |
| Market Cap | $4.91M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 56 |
| Short Interest | 0.87% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Sonnet BioTherapeutics Holdings Inc
Sector
Health Care
Industry
Biotechnology
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has devel...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sonnet BioTherapeutics (SONN) stock?
You can purchase shares of Sonnet BioTherapeutics (NASDAQ:SONN) through any online brokerage.
Who are Sonnet BioTherapeutics (SONN) competitors?
Other companies in Sonnet BioTherapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), CERo Therapeutics Hldgs (NASDAQ:CERO), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI) and Synaptogenix (NASDAQ:SNPX).
What is the forecast, or price target, for Sonnet BioTherapeutics (SONN) stock?
Sonnet BioTherapeutics has a consensus price target of $9.12.
What is the current price for Sonnet BioTherapeutics (SONN)?
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $0.9439 last updated September 23, 2024 at 3:50 PM EDT.
Does Sonnet BioTherapeutics (SONN) pay a dividend?
There are no upcoming dividends for Sonnet BioTherapeutics.
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics’s Q4 earnings are confirmed for Thursday, December 12, 2024.
Is Sonnet BioTherapeutics (SONN) going to split?
There is no upcoming split for Sonnet BioTherapeutics.
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.